Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 07, 2022

SELL
$187.54 - $223.02 $1,875 - $2,230
-10 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$281.15 - $329.69 $2,811 - $3,296
10
10 $3,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Peoples Financial Services Corp. Portfolio

Follow Peoples Financial Services Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Financial Services Corp., based on Form 13F filings with the SEC.

News

Stay updated on Peoples Financial Services Corp. with notifications on news.